Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01819324 · ClinicalTrials.gov registry record · NA

A Lifestyle Intervention for Breast Cancer Survivors

A NA study, sponsored by Hartford Hospital.

Completed
Registry status
NA
Development phase
173
Enrollment target

NCT01819324: Completed NA study, sponsored by Hartford Hospital.

NCT01819324 is a NA study that has completed, run by Hartford Hospital. The registered enrollment target is 173 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01819324, a NA study, has completed, sponsored by Hartford Hospital.

COMPLETED
Registry status
NA
Development phase
173 participants
Enrollment target

Study Summary

1. The purpose of the study is to test the effectiveness of a new mail-based intervention for breast cancer survivors compared with standard lifestyle management and no-treatment. 2. This intervention addresses both lifestyle factors such as dietary and physical activities and psychological issues specific to breast cancer survivors to improve healthy behaviors.

Primary Outcome

Diet habits (amount of fat and fruit/vegetable uptake) will be assessed at 3 times: at baseline, at the end of the 4 months, and at the end of 7 months.

Interventions

  • BEHAVIORAL Targeting the Teachable Moment
  • BEHAVIORAL Standardized Lifestyle Management

Trial Details

FieldValue
Enrollment Target 173 participants
Start Date 2011-04
Est. Completion 2015-07
Phase NA
Hartford Hospital

75 total trials

What the finished NCT01819324 record still lists

NCT01819324 is an interventional study that assigns participants to a tested intervention. The registered 173 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 2 interventions - of which Targeting the Teachable Moment is the first listed.

NCT01819324 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01819324 about?

NCT01819324 is a clinical study titled "A Lifestyle Intervention for Breast Cancer Survivors". 1. The purpose of the study is to test the effectiveness of a new mail-based intervention for breast cancer survivors compared with standard lifestyle management and no-treatment. 2. This intervention addresses both lifestyle factors such as dietary and physical activities and psychological issues s...

What is the current status of trial NCT01819324?

This trial is currently completed. It is a NA study. The enrollment target is 173 participants. The study started on 2011-04. Estimated completion is 2015-07.

What interventions are being tested in trial NCT01819324?

The interventions under investigation include: Targeting the Teachable Moment (BEHAVIORAL), Standardized Lifestyle Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT01819324?

This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01819324's enrollment target sits among peer trials

173 611th of 2000 higher than 1,389 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05568719 · 173 participants · Phase 3

    Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

  • NCT07070115 · 173 participants · NA

    Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®

  • NCT07150832 · 173 participants · NA

    Efficacy of the I-CARE Digital Health Intervention

  • NCT01000259 · 174 participants

    Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01819324, the US trial registry maintained by the National Library of Medicine. NCT01819324 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.